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Moyamoya disease (MD) is a chronic, progressive cerebrovascular disease distinguished by bilateral stenosis or occlusion of the
arteries around the circle of Willis with resulting prominent arterial collateral circulation. We describe a pregnant woman in
whom this diagnosis was conﬁrmed by cerebral angiogram and treated with bilateral superﬁcial temporal artery-middle cerebral
artery (STA-MCA) bypass grafting prior to conception. The patient was managed with strict blood pressure monitoring and low-
dose aspirin antepartum, intrapartum, and postpartum. The patient presented in spontaneous labor at term and underwent a
spontaneous vaginal delivery without complications.
1.Introduction
MD is a progressive cerebrovascular disease distinguished
by bilateral stenosis or occlusion of the arteries supplying
the circle of Willis and resulting in a prominent arterial
collateral circulation. The disease is characterized by intimal
thickening in the walls of the internal carotid arteries
bilaterally. Intraventricular, subarachnoid, and intracerebral
hemorrhage has been described with MD. There is a paucity
of the literature regarding management during pregnancy.
We present a case of a woman with MD who underwent
intracranial bypass grafting prior to conception and subse-
quently underwent a successful vaginal delivery.
2.Case
A 30-year-old right-handed African American presented for
prenatal care at 10 weeks of gestation. The patient had
a past medical history that was signiﬁcant for a “stroke”
in 1999. In 2008, the patient presented to the emergency
department (ED) with diﬃculty using her right hand and
transient left-sided weakness and numbness. A preliminary
diagnosis of transient ischemic attack (TIA) was made. Her
evaluationatthattimeincludedanMRIwhichdemonstrated
encephalomalacia in the right frontal cortex; MRA at that
time demonstrated “irregular vessels” but was otherwise
interpreted as unremarkable.
A follow-up evaluation by a neurosurgeon conﬁrmed
the diagnosis of MD based upon ﬁndings at a cerebral
angiogram. Please see Figures 1(a) and 1(b) for images from
her cerebral angiogram. The patient underwent bilateral
STA-MCA bypass grafting. One month following the second
procedure the patient presented to the ED with aphasia and
right hemiplegia. Evaluation revealed a left basal ganglia
hemorrhage. Her symptoms subsequently resolved.
The patient was asymptomatic upon her presentation
to George Washington University Medical Center Prenatal
Clinic at 10 weeks of pregnancy. Her blood pressure was
136/86 and her weight 263 pounds. The patient had stopped
taking low-dose aspirin when she learned she was pregnant,
butlow-doseaspirinwassubsequentlyre-initiated.Herpreg-
nancy was managed with home blood pressure monitoring,
and her BP remained less than 140/90 throughout gestation.
Noantihypertensivemedicationswerenecessary.Ultrasound
demonstrated a normal fetus, and serial ultrasounds docu-
mented normal growth.2 Case Reports in Obstetrics and Gynecology
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Figure 1: The attached pictures are digitally subtracted images from a cerebral angiogram of our patient. (a) Right vertebral injection
showing irregular, serpiginous ill-deﬁned vessels. (b) Left vertebral injection showing similar ﬁndings.
The patient presented in spontaneous labor at term.
An epidural anesthetic was placed, and she underwent an
unremarkable labor. Her second stage lasted 1 hour, and she
was not actively managed. Blood pressure was monitored
every 30min and remained at less than 140/90. She had
a spontaneous vaginal delivery without complications of a
2850 gram female infant with Apgar scores of 9 and 9 at one
and ﬁve minutes, respectively.
3. Discussion
MD is a rare chronic progressive cerebrovascular disease
distinguished by bilateral stenosis or occlusion of the arterial
supplytothecircleofWillis.TheetiologyofMDisunknown,
but there is a higher incidence among the Japanese and other
Asian populations. A familial inheritance occurs in approx-
imately 10 percent of cases [1]. These cases are theorized
to be inherited as an autosomal dominant with incomplete
penetrance [2]. A speciﬁc gene locus has been described on
chromosome 17 although involvement of chromosomes 3, 6,
8, and 12 has been reported by others [2].
“Moyamoya” is a Japanese word meaning puﬀyo rh a z y ,
like “a puﬀ of smoke in the air.” The term was originally
used to describe the angiographic appearance of the aﬀected
vascular collateral network [3]. In epidemiologic surveys
conducted in Japan, the prevalence of Moyamoya has been
found to be 3.2 to 10.5 per 100,000 population, with a
slight female predominance [4–6]. In an American study, the
breakdownofprevalencebasedonethnicityasratiotowhites
was 4.6 for Asian Americans, 2.2 for African Americans, and
0.5 for Hispanics [7].
Clinical features of MD include cerebrovascular events
suchasTIA,infarction,andhemorrhagicstroke.Diagnosisis
suggested by cranial CT or MRI. Diagnosis utilizing vascular
imaging with MRA, CTA, or conventional cerebral angiogra-
phy is conﬁrmed by demonstrating the stenotic or occlusive
lesions found in the distal internal carotid arteries and the
arteries proximal to the circle of Willis. Pathologically, MD
appears as concentric stenosis or occlusion in the distal
internal carotid arteries and large vessels of the circle of
Willis. The vessels appear as a meshwork of overgrown and
dilated small arteries.
There is no deﬁnitive treatment for Moyamoya disease
other than neurosurgical palliation. Individuals experienc-
ing TIAs and strokes are prescribed aspirin, vasodilators,
or anticoagulants to reduce the risks of future recurrent
neurological sequelae [8].
T h e r eh a v eb e e na tl e a s t5 7c a s e so fM Di np r e g n a n c y
described in the literature. 34 patients had been diagnosed
with MD prior to pregnancy and 23 patients were symp-
tomatic and diagnosed initially as having MD associated
with pregnancy [9, 10]. The majority of cases reported have
initially presented as an initial intracranial hemorrhage with
neurological dysfunction [11, 12].
Autoregulation of cerebral blood ﬂow is challenged dur-
ingpregnancybyhypervolemia,hyperventilation,andawide
range of systemic blood pressures particularly in the third
trimester. The presence of a vascular disease like MD poses
a potential risk of ischemia and/or cerebral hemorrhage,
during pregnancy, labor, or delivery.
Few reports of the management of pregnancy and
delivery in pregnancy associated with MD are available for
review. Authors agree that blood pressure must be strictly
controlled [13].
Medicalmanagementincludesantiplatelettreatmentand
blood pressure control. As in our patient, aspirin therapy
was continued. Theoretically, aspirin can decrease risk of
microemboli, which is a possible cause of ischemic disease
in Moyamoya [14]. Risk of thrombosis is also increased
in pregnancy; thus, aspirin may even be more essential
during this period. Calcium channel blockers and magne-
sium sulphate may be best choices to control hypertension
in Moyamoya because of their vasodilatory eﬀects, which
can reduce gravity of ischemic episodes [14]. Additionally,Case Reports in Obstetrics and Gynecology 3
in pregnancy, calcium channel blockers and magnesium
may have the extra beneﬁt of treating pregnancy-related
hypertension or preventing seizures in preeclampsia.
The preferred mode of delivery remains unclear. Cesare-
andelivery waschosenin the majority ofpreviouslyreported
cases. This approach has been suggested to better control
ﬂuctuations in blood pressure and potential alterations in
cerebral blood ﬂow that may occur during the active and
second stage of labor. Elective cesarean delivery has been
suggested to be the delivery mode of choice of the initial
symptoms and diagnosis of MD was made during pregnancy
[15]. Since cerebral blood ﬂow is minimally aﬀected by
neural inﬂuences and the resultant eﬀects of anesthesia may
not play as large of a role in changes of intracranial pressure
as they do in systemic pressure, not all authors are in
agreement [16].
Given the dramatic increase in intravascular volume that
accompanies placental separation regardless of the mode
of delivery, vaginal delivery with regional anesthesia would
seem to be a reasonable approach. Women with MD having
had vaginal deliveries without neurological sequelae have
been reported [10, 17]. Regional anesthesia is generally
regarded as the preferred modality of analgesia as it pro-
vides easier monitoring for neurological changes as well as
decreasing the risk of signiﬁcant hypertension associated
with intubation required for general anesthesia.
The present patient had two prior neurosurgical proce-
dures. There is limited experience reported with intracranial
vascular grafting under any circumstances in pregnancy.
Patients who have undergone revascularization procedures
were still at a signiﬁcant risk for bleeding with MD [12].
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